Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1830 participants.
Also called NCT02137187
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,830 participants
- Sponsor
- Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
- Registry
-
NCT02137187
-
- Other papers using this trial's data
- AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT02137187. Randomized; no masking; primary purpose treatment. Start 2014-10-15 (actual); primary completion 2021-05-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
- Acronym
- APAF-CRT
- Condition
- Permanent Atrial Fibrillation
- Intervention (Procedure)
- AV junction ablation
- Intervention (Device)
- CRT
- Intervention (Drug)
- Optimized drug therapy
- Intervention (Device)
- ICD
- Lead sponsor
- Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
Record details
- Record id
cardio:ct-nct02137187- Content hash
a1a555971a53414002e11c182b6b06cfbb065b421280edfc05e9ea231fce9a8c